TCL Archive Upton Promises “Minimal Disruption” As Result of Changes; Centers Program Probably To Move January 20, 1978
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas January 27, 2012
TCL Archive In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center December 7, 2012
